Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This Clinical …

Background The stability and propagation of hepatitis C virus (HCV) is dependent on a
functional interaction between the HCV genome and liver-expressed microRNA-122 (miR-122). …

… lecture activities or patents from Merck, Janssen, Roche, Gilead, and Medtronic, and research
grants from Merck and Roche. Dr Janssen reported receiving financial compensation for …

Background Treatment of HBeAg-positive patients with chronic hepatitis B is not effective in
most. A combination of immunomodulatory pegylated interferon alfa-2b and antiviral …

Background: Clinical outcomes of chronic hepatitis C infection in patients with advanced
fibrosis include liver failure, hepatocellular carcinoma, and death. Objective: To investigate …

Chronic hepatitis B virus (HBV) infection is characterized by a weak immune response to
HBV. Regulatory T cells (T reg ) can suppress the function of effector T cells and may thus be …

Background & Aims Risk scores for hepatocellular carcinoma (HCC) developed in Asians
offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This …

Cirrhosis of the liver is frequently accompanied by complex alterations in the hemostatic
system, resulting in a bleeding tendency. Although many hemostatic changes in liver disease …

Current recommendations for early anticoagulation in acute portal vein thrombosis unrelated
to cirrhosis or malignancy are based on limited evidence. The aim of this study was to …

Hepatitis B virus (HBV) is a hepatotropic virus that can establish a persistent and chronic
infection in humans through immune anergy. Currently, 3.5% of the global population is …